Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells

Fig. 3

Celecoxib arrests KBM5 and KBM5-T315I cells at cell cycle G1 phase. a The two cell lines were treated with 0, 20, 40, 60, 80 μM celecoxib for 24 h. Flow cytometry analysis was conducted for the cell-cycle distribution. b The graph showed the percentage of cells in each stage of the cell cycle. Data were mean ± SD (n = 3). *p < 0.05, **p < 0.01

Back to article page